<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is primarily a lifestyle disease of the western world </plain></SENT>
<SENT sid="1" pm="."><plain>As such it can be likened to <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and indeed it shares many of the same risk factors </plain></SENT>
<SENT sid="2" pm="."><plain>It is therefore perhaps unsurprising that cholesterol metabolism and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are also intricately linked </plain></SENT>
<SENT sid="3" pm="."><plain>Many of the initial studies suggesting a link between dietary cholesterol, blood cholesterol levels and cholesterol lowering drugs were performed more than a decade ago </plain></SENT>
<SENT sid="4" pm="."><plain>The most recent insights in this field are the result of meta-analyses, advances in pharmacogenetics and the new field of molecular pathological epidemiology </plain></SENT>
<SENT sid="5" pm="."><plain>This review summarises the current evidence linking cholesterol metabolism with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> including the suggested underlying molecular causes and the implications for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> prevention </plain></SENT>
</text></document>